课题基金 / 基金详情

Research Training Fellowship in Substance Abuse

Research Training Fellowship in Substance Abuse
药物滥用研究培训奖学金
批准号:
10625280
负责人:
BRIAN D. KILUK
金额:
$13.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
未结题
起止时间:
1988-07-01 至 2026-06-30

项目摘要

项目成果

BRIAN D. KILUK的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 这是T32培训计划的竞争性更新,实质上是研究培训奖学金 虐待方案(RTFSA-P),自1988年以来一直存在。尽管最近在 了解成瘾的神经生物学,在应用所获得的知识方面存在持续的差距。 从成瘾领域的基础科学研究到临床实践。新一代的行为, 精神药理学、神经影像、分子遗传学和分子神经科学的研究具有广阔的前景 临床意义和这些研究带来了弥合基础研究和临床研究之间差距的潜力。 尽管现有科学的质量,弥合这一差距的实际进展也取决于 提供受过适当培训的年轻科学家。RTFSA-P的目的是通过以下方式满足这一需求 为4名对翻译或翻译行业感兴趣的医生或博士提供博士后培训 成瘾领域的干预研究。拟议的RTFSA-P是该司的一个为期两年的方案 上瘾(DA),耶鲁医学院精神病学系,并将支付博士后实习生 在他们职业生涯的初始阶段,有机会投入几乎全部的时间精力来发展 成为临床或翻译领域的独立研究人员所需的技能和经验 物质使用障碍的研究。DA是一个持续的、稳定的成瘾研究项目,现在 涵盖123个主要资助项目,其中包括4个中心,涵盖广泛的主题和 研究方法。这促进了从临床前快速和双向发展的研究 从项目(“工作台”)到临床研究(“床边”和“社区”)。申请者将是医学博士或博士后 接受过精神病学、内科、临床心理学等专业培训的候选人 神经科学。候选人将由招生委员会根据他们的优秀潜力进行挑选。 在成瘾的翻译或干预研究领域。RTFSA-P计划包括(1) 个性化研究指导,(2)成功完成翻译研究项目,(3)核心 课程,包括关于成瘾临床研究和治疗、生物统计和研究的研讨会 设计、负责任的科学研究和拨款撰写技能以及(4)个性化参与 参加院系、医学院和大学感兴趣的研讨会。培训设施包括 耶鲁大学医学院精神病学系附属的主要机构。在……结束时 经过培训,申请者将非常适合从事翻译或干预研究的独立职业。 上瘾的领域。
英文摘要
Project Summary/Abstract This is the competitive renewal of a T32 training program, the Research Training Fellowship in Substance Abuse Program (RTFSA-P), which has been in existence since 1988. Despite recent advances in understanding the neurobiology of addiction, there is a persistent gap in the application of knowledge gained from basic science studies to clinical practice in the field of addiction. A new generation of behavioral, psychopharmacology, neuroimaging, molecular genetics and molecular neuroscience studies has broad clinical implications and these studies bring the potential to bridge the gap between basic and clinical research. Despite the quality of the available science, actual progress in bridging this gap depends also upon the availability of appropriately trained young scientists. The purpose of the RTFSA-P is to meet this need by providing post-doctoral training for a total of 4 physicians or PhDs interested in careers in translational or intervention research in the field of addiction. The proposed RTFSA-P is a two-year program in the Division of Addictions (DA), Department of Psychiatry, Yale School of Medicine, and will afford post-doctoral trainees the opportunity to devote virtually full-time effort, during the initial phase of their careers, to developing the skills and experience needed to become independent researchers in the field of clinical or translational research in substance use disorders. The DA is an ongoing, stable addiction research program that now encompasses over 123 major funded projects including 4 Centers covering a broad scope of topics and research methodologies. This facilitates research that moves rapidly and in both directions from preclinical projects (“bench”) to clinical studies (“bedside” and “community”). Applicants will be MDs or PhD post-doctoral candidates trained in specialties that include psychiatry, internal medicine, clinical psychology, or neuroscience. Candidates will be selected by an admission committee based on their potential for excellence in the field of translational or intervention research in addictions. The RTFSA-P program includes (1) individualized research preceptorship, (2) successful completion of a translational-research project, (3) a core curriculum, which includes seminars on addiction clinical research and treatment, biostatistics and research design, the responsible conduct of scientific research and grant writing skills and (4) individualized participation in seminars of interest in the Department, Medical School and University. The training facilities include the major institutions affiliated with Yale School of Medicine, Department of Psychiatry. At the conclusion of training, applicants will be well suited for independent careers in translational or intervention research in the field of addiction.
期刊论文(174)
专著(0)
科研奖励(0)
会议论文
Concurrent effects of acute intravenous cocaine in context of chronic desipramine in humans.
急性静脉注射可卡因与慢性地昔帕明对人类的并发影响。
DOI: --
发表时间: 1990
期刊: NIDA research monograph
影响因子: --
作者: [Pickett,G, Kosten,TR, Gawin,FH, Byck,R, Fleming,J, Silverman,D, Kosten,TA, Jatlow,P]
通讯作者: Jatlow,P
DOI: --
发表时间: 1990
期刊: NIDA research monograph
影响因子: --
作者: [Diakogiannis,IA, Steinberg,M, Kosten,TR]
通讯作者: Kosten,TR
DOI: 10.1016/j.biopsych.2008.05.024
发表时间: 2008-12-01
期刊: BIOLOGICAL PSYCHIATRY
影响因子: 10.6
作者: [Brewer, Judson A., Worhunsky, Patrick D., Carroll, Kathleen M., Rounsaville, Bruce J., Potenza, Marc N.]
通讯作者: Potenza, Marc N.
Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
伐尼克兰对重度饮酒者认知表现的影响:剂量反应效应以及与饮酒结果的关联。
DOI: 10.1037/pha0000161
发表时间: 2018
期刊: Experimental and clinical psychopharmacology
影响因子: 2.3
作者: [Roberts,Walter, McKee,SherryA]
通讯作者: McKee,SherryA
106
    Development of the Opioid Use Disorder Severity Scale
    • 批准号:
      10202544
    • 项目类别:
    • 资助金额:
      $56.15万
    • 财政年份:
      2020
    • 负责人:
      BRIAN D. KILUK
    • 依托单位:
    Development of the Stimulant Use Disorder Severity Scale
    • 批准号:
      10608337
    • 项目类别:
    • 资助金额:
      $16.38万
    • 财政年份:
      2020
    • 负责人:
      BRIAN D. KILUK
    • 依托单位:
    Development of the Opioid Use Disorder Severity Scale
    • 批准号:
      10376790
    • 项目类别:
    • 资助金额:
      $55.56万
    • 财政年份:
      2020
    • 负责人:
      BRIAN D. KILUK
    • 依托单位:
    Development of the Opioid Use Disorder Severity Scale
    • 批准号:
      10045652
    • 项目类别:
    • 资助金额:
      $56.86万
    • 财政年份:
      2020
    • 负责人:
      BRIAN D. KILUK
    • 依托单位:
    海外基金